Myths vs facts: HbA1c and menopause

The question of myths vs facts regarding HbA1c and menopause is not directly addressed in the provided context. Generally, HbA1c reflects average blood glucose over 2–3 months. During menopause, hormonal shifts (declining estrogen) can reduce insulin sensitivity, potentially raising HbA1c. However, the effect varies individually and is influenced by lifestyle, weight, and genetics. DNA tests specifically predicting HbA1c changes during menopause lack robust validation. Current evidence is weak: no strong GWAS links menopause directly to HbA1c via single SNPs. Many claims are based on associations with insulin resistance or lipid metabolism, not causal pathways. Bottom line: HbA1c is a useful clinical marker, but genetic testing for menopause-related HbA1c changes is not evidence-based. Rely on medical guidance and lifestyle interventions.